comparemela.com

Latest Breaking News On - Novo wegovy - Page 1 : comparemela.com

Transcripts For CNBC Worldwide 20240704

Investment in chinese technology. Later on, renting in manhattan just got a lot more expensive. Its thursday, august 10th, 2023 you are watch wiing Worldwide Exchange here on cnbc good morning welcome to Worldwide Exchange. Im dominic chu in for Frank Holland this morning lets kickoff the morning with the down day for the stock market s p is implied higher 24 points. Dow jones industrial average is 17 177. Investors are geeg gearing up for the latest read at 8 30 a. M. For consumer prices. The estimates right now are for 3. 3 gain year over year after the 3 gain for the july cpi checking on the bond market with the cpi print. Benchmark yields are rising. 10year treasury is 4. 018 2year treasury at 4. 811 . In energy, energy could be a key driver of the inflation story this time around you see wti crude at 84. 65. That is up. 30 . Ice brent crude futures at 87. 85 nat gas prices which were on a tear yesterday, is flat today. Time for the mornings big money mover. That is disney Silvana

Gilead Stock Jumps After Its Weight-Loss Drug Emerges From Under The Radar

Gilead stock jumped Friday after surprising Wall Street with preclinical test results for an under-the-radar weight-loss drug.

Weight-loss drug forecasts jump to $150 billion as supply grows

As millions seek access to weight-loss drugs from Novo Nordisk and Eli Lilly , increasing supplies, possible wider usage and a growing number of would-be rivals are leading some experts to raise annual global sales forecasts for the treatments to about $150 billion by the early 2030s.

Weight-loss drug sale forecasts jump to $150bn as supply grows

Obesity Drug Stocks: Where to Invest Now

Obesity Drug Stocks: Where to Invest Now
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.